01 1SM BIOMED
01 1ERYTHROMYCIN STEARATE USP
01 1Malaysia
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-01-03
Pay. Date : 2017-10-24
DMF Number : 32120
Submission : 2017-11-16
Status : Active
Type : II
20
Sm Biomed Sdn Bhd, based in Malaysia, is a pharmaceutical company.
One of their notable products is ERYTHROMYCIN STEARATE USP, with a corresponding US DMF Number 32120.
Remarkably, this DMF maintains an Active status since its submission on November 16, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 03, 2018, and payment made on October 24, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II
